Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the efficacy and safety of Brensocatib in adults with moderate to severe hidradenitis suppurativa. The trial status is ACTIVE_NOT_RECRU…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brensocatib (brensocatib)

Snippet

Sponsor: Insmed Incorporated | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: ACTIVE_NOT_RECRUITING